{"id":"https://openalex.org/W2095046563","doi":"https://doi.org/10.1159/000119254","title":"Amantadine versus Biperiden: A Double-Blind Study of Treatment Efficacy in Neuroleptic Extrapyramidal Movement Disorders","display_name":"Amantadine versus Biperiden: A Double-Blind Study of Treatment Efficacy in Neuroleptic Extrapyramidal Movement Disorders","publication_year":2008,"publication_date":"2008-02-26","ids":{"openalex":"https://openalex.org/W2095046563","doi":"https://doi.org/10.1159/000119254","mag":"2095046563","pmid":"https://pubmed.ncbi.nlm.nih.gov/8927233"},"language":"en","primary_location":{"id":"doi:10.1159/000119254","doi":"https://doi.org/10.1159/000119254","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000119254","pdf_url":null,"source":{"id":"https://openalex.org/S147539111","display_name":"Neuropsychobiology","issn_l":"0302-282X","issn":["0302-282X","1423-0224"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"P. K\u00f6nig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. K\u00f6nig","raw_affiliation_strings":["Psychiatric Hospital, Rankweil, Austria","Psychiatric Hospital, Rankweil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Hospital, Rankweil, Austria","institution_ids":[]},{"raw_affiliation_string":"Psychiatric Hospital, Rankweil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062036020","display_name":"Karin Chwatal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"K. Chwatal","raw_affiliation_strings":["University of Vienna, Medical Statistics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vienna, Medical Statistics","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110156387","display_name":"Liselotte Havelec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129774422","display_name":"University of Vienna","ror":"https://ror.org/03prydq77","country_code":"AT","type":"education","lineage":["https://openalex.org/I129774422"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"L. Havelec","raw_affiliation_strings":["University of Vienna, Medical Statistics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vienna, Medical Statistics","institution_ids":["https://openalex.org/I129774422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083239954","display_name":"F. Riedl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Riedl","raw_affiliation_strings":["Psychiatric Hospital, Rankweil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Hospital, Rankweil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010026963","display_name":"H. Schubert","orcid":"https://orcid.org/0000-0002-8380-5394","observed_orcids":["https://orcid.org/0000-0002-8380-5394"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Schubert","raw_affiliation_strings":["Psychiatric Hospital, Hall"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Hospital, Hall","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023657873","display_name":"H. Schultes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120342","display_name":"Universit\u00e4tsklinikum Krems","ror":"https://ror.org/02r2nns16","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210120342"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"H. Schultes","raw_affiliation_strings":["Psychiatric Practice, Krems, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Practice, Krems, Austria","institution_ids":["https://openalex.org/I4210120342"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8944,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.7606215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"33","issue":"2","first_page":"80","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amantadine","display_name":"amantadine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/biperiden","display_name":"biperiden","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.925000011920929},{"id":"https://openalex.org/keywords/anticholinergic-drugs","display_name":"anticholinergic agents","score":0.7590000033378601},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/levomepromazine","display_name":"levomepromazine","score":0.8529999852180481},{"id":"https://openalex.org/keywords/antiparkinsonian-drugs","display_name":"antiparkinsonian drugs","score":0.7749999761581421},{"id":"https://openalex.org/keywords/glutamate-hypothesis","display_name":"glutamate hypothesis","score":0.671999990940094},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7534540295600891},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.6904377937316895},{"id":"https://openalex.org/C2777374534","wikidata":"https://www.wikidata.org/wiki/Q409761","display_name":"Amantadine","level":2,"score":0.6072413325309753},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.5649610161781311},{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.555419921875},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5128648281097412},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.488784521818161},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4816352427005768},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4638739824295044},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.459168016910553},{"id":"https://openalex.org/C2778261627","wikidata":"https://www.wikidata.org/wiki/Q2608695","display_name":"Movement disorders","level":3,"score":0.45543986558914185},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.4469425678253174},{"id":"https://openalex.org/C2780656706","wikidata":"https://www.wikidata.org/wiki/Q417204","display_name":"Levomepromazine","level":4,"score":0.43232762813568115},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4309554398059845},{"id":"https://openalex.org/C2779271588","wikidata":"https://www.wikidata.org/wiki/Q416414","display_name":"Tiapride","level":2,"score":0.42382943630218506},{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.42026451230049133},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.4154154658317566},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.33941569924354553},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.329856812953949},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.27659130096435547},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24449175596237183},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.13469141721725464},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.08761215209960938},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000547","descriptor_name":"Amantadine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000547","descriptor_name":"Amantadine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001712","descriptor_name":"Biperiden","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001712","descriptor_name":"Biperiden","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009069","descriptor_name":"Movement Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000119254","doi":"https://doi.org/10.1159/000119254","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000119254","pdf_url":null,"source":{"id":"https://openalex.org/S147539111","display_name":"Neuropsychobiology","issn_l":"0302-282X","issn":["0302-282X","1423-0224"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"journal-article"},{"id":"pmid:8927233","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8927233","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087997321","https://openalex.org/W1413906703","https://openalex.org/W2029568733","https://openalex.org/W2023557681","https://openalex.org/W2410053658","https://openalex.org/W2225426024","https://openalex.org/W2315603792","https://openalex.org/W2080141342","https://openalex.org/W2414884485","https://openalex.org/W2043371379"],"abstract_inverted_index":{"Anticholinergic":[0],"treatment":[1,106,122,198,240,247,281],"of":[2,13,20,34,47,60,93,107,121,133,138,249,259,263,273,279,282,290],"neuroleptic":[3,38,264],"extrapyramidal":[4],"movement":[5],"disorders":[6],"(EPS)":[7],"has":[8],"been":[9,41],"associated":[10],"with":[11,80,88,171,222,284],"induction":[12],"tardive":[14,293],"dyskinesia.":[15],"Also":[16],"an":[17],"increasing":[18],"abuse":[19],"anticholinergics":[21],"by":[22],"schizophrenic":[23,53],"patients":[24,54,168,201],"is":[25,269],"noted.":[26],"Since":[27],"as":[28,30,220],"early":[29],"1976,":[31],"positive":[32],"effects":[33,126,146],"amantadine":[35],"(AMA)":[36],"on":[37,156,252],"EPS":[39,70,109,129,253,265,283],"have":[40],"described,":[42],"therefore":[43],"a":[44,72,228,270],"controlled":[45],"study":[46,65],"these":[48],"reports":[49],"seemed":[50],"worthwhile.":[51],"Forty-two":[52],"(of":[55],"which":[56],"7":[57,78],"were":[58,67,103,127,154,169],"dropouts)":[59],"three":[61],"centers":[62],"entered":[63],"the":[64,131,144,179,196,207,223,246,257,287],"and":[66,82,98,123,147,163,173,178,268,292],"treated":[68,170],"for":[69,130,136,142,183,204],"in":[71,105,192,206,261],"double-blind":[73],"design:":[74],"18":[75],"(11":[76],"m,":[77,85],"f)":[79,87],"AMA":[81,94,197,260,280],"17":[83],"(8":[84],"9":[86],"biperiden":[89],"(BIP).":[90],"Identical":[91],"preparations":[92],"100":[95],"mg,":[96,101],"tid)":[97,102],"BIP":[99,208],"(2":[100],"used":[104],"haloperidol-induced":[108],"(AMA,":[110],"mean":[111,116],"22.4":[112],"mg":[113,118],"haloperidol;":[114],"BIP,":[115],"19.6":[117],"haloperidol).":[119],"Effects":[120],"possible":[124],"side":[125,145],"rated:":[128],"intensity":[132],"EPS,":[134],"BPRS":[135],"quantification":[137],"psychotic":[139],"symptoms,":[140],"FSUCL":[141],"rating":[143,225],"KUSTA":[148],"to":[149,286],"document":[150],"patients'":[151],"mood.":[152],"Ratings":[153],"recorded":[155,221],"days":[157],"0,":[158],"3,":[159],"7,":[160],"14,":[161],"28":[162],"at":[164],"discontinuation,":[165],"respectively.":[166],"All":[167,218],"haloperidol":[172],"levomepromazine":[174],"(for":[175],"tranquilization/sleep":[176],"induction)":[177],"respective":[180],"antiparkinsonian":[181],"agent":[182],"14":[184],"days.":[185],"Patient":[186],"characteristics":[187],"did":[188],"not":[189],"differ":[190],"significantly":[191],"either":[193],"groups.":[194],"In":[195],"group,":[199,209],"2":[200],"dropped":[202],"out":[203],"noncompliance,":[205,215],"5":[210],"(3":[211],"no":[212,236],"effect,":[213],"1":[214,216],"agitation).":[217],"results":[219],"different":[224],"instruments":[226],"showed":[227],"significant":[229,237],"(p":[230],"<":[231],"0.01)":[232],"overall":[233],"improvement,":[234],"whereas":[235],"differences":[238],"between":[239],"groups":[241],"could":[242],"be":[243],"determined,":[244],"notably":[245],"effect":[248],"both":[250],"drugs":[251],"was":[254],"similar.":[255],"Thus,":[256],"application":[258],"cases":[262],"seems":[266],"justified":[267],"useful":[271],"alternative":[272],"anticholinergic":[274],"drugs.":[275],"Certain":[276],"advantageous":[277],"aspects":[278],"regard":[285],"glutamate":[288],"hypothesis":[289],"schizophrenia":[291],"dyskinesia":[294],"are":[295],"discussed.":[296]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}